TECAN LIMITED
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Fabricated Structural Metal, Miscellaneous Structural Metal Work, Fabricated Metal Products, Not Elsewhere Classified, Manufacturing Industries, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about TECAN LIMITED
Live alerts from global media, monitored by Business Radar
2025-01-21 (ddw-online.com)
Lab automation to optimise data processing and maximise throughput - Drug Discovery World (DDW)
Digital tools and walkaway time allow scientists to accelerate their research, says Mukta Acharya, Head of Life Sciences Business Division, Tecan.
Read more
2025-01-21 (ddw-online.com)
Lab automation to optimise data processing and maximise throughput - Drug Discovery World (DDW)
Digital tools and walkaway time allow scientists to accelerate their research, says Mukta Acharya, Head of Life Sciences Business Division, Tecan.
Read more
2024-12-02 (nature.com)
Borrelia PeptideAtlas A proteome resource of common Borrelia burgdorferi isolates for Lyme research Scientific Data
Scientific Data - Borrelia PeptideAtlas: A proteome resource of common Borrelia burgdorferi isolates for Lyme research
Read more
2024-04-02 (selectscience.net)
Evaluation of a Steroid Panel LC-MS Kit
Tecan highlights results from a study using a Steroid Panel LC-MS Kit for steroid research
Read more
2024-02-02 (selectscience.net)
Continuous mRNA manufacturing to boost vaccine production
New mRNA-based therapies and vaccines could be developed more quickly and cheaply thanks to new manufacturing technology
Read more
2023-03-14 (marketscreener.com)
TECAN GROUP AG
Tecan Annual Report 2022 The fight against cancer Tecan's role in fighting cancer: from research to clinic ... | March 14, 2023
Read more
2023-03-14 (marketscreener.com)
TECAN GROUP AG
Tecan Annual Report 2022 The fight against cancer Tecan's role in fighting cancer: from research to clinic ... | March 14, 2023
Read more
2021-11-18 (nature.com)
Mapping protein carboxymethylation sites provides insights into their role in proteostasis and cell proliferation | Communications
Posttranslational mechanisms play a key role in modifying the abundance and function of cellular proteins. Among these, modification by advanced glycation end products has been shown to accumulate during aging and age-associated diseases but specific protein targets and functional consequences remain largely unexplored. Here, we devise a proteomic strategy to identify sites of carboxymethyllysine modification, one of the most abundant advanced glycation end products. We identify over 1000 sites of protein carboxymethylation in mouse and primary human cells treated with the glycating agent glyoxal. By using quantitative proteomics, we find that protein glycation triggers a proteotoxic response and indirectly affects the protein degradation machinery. In primary endothelial cells, we show that glyoxal induces cell cycle perturbation and that carboxymethyllysine modification reduces acetylation of tubulins and impairs microtubule dynamics.
Read more